Inflammatory Biomarkers Aid in Diagnosis of Dementia
Dual pathology of Alzheimer's disease (AD) and vascular cognitive impairment and dementia (VCID) commonly are found together at autopsy, but mixed dementia (MX) is difficult to diagnose during life. Biological criteria to diagnose AD have been defined, but are not available for vascular disease...
Main Authors: | Erik B. Erhardt, John C. Adair, Janice E. Knoefel, Arvind Caprihan, Jillian Prestopnik, Jeffrey Thompson, Sasha Hobson, David Siegel, Gary A. Rosenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.717344/full |
Similar Items
-
A Multimodal Approach to Stratification of Patients with Dementia: Selection of Mixed Dementia Patients Prior to Autopsy
by: Gary A. Rosenberg, et al.
Published: (2019-08-01) -
Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease
by: Annika Öhrfelt, et al.
Published: (2011-01-01) -
A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
by: Marco Vinceti, et al.
Published: (2017-12-01) -
Qualitative Assessment of Longitudinal Changes in Phenocopy Frontotemporal Dementia
by: Rozanna Meijboom, et al.
Published: (2019-11-01) -
Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
by: Anna Rosenberg, et al.
Published: (2019-12-01)